BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tsuei J, Chau T, Mills D, Wan YJ. Bile acid dysregulation, gut dysbiosis, and gastrointestinal cancer. Exp Biol Med (Maywood) 2014;239:1489-504. [PMID: 24951470 DOI: 10.1177/1535370214538743] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 5.8] [Reference Citation Analysis]
Number Citing Articles
1 Khan TJ, Hasan MN, Azhar EI, Yasir M. Association of gut dysbiosis with intestinal metabolites in response to antibiotic treatment. Human Microbiome Journal 2019;11:100054. [DOI: 10.1016/j.humic.2018.11.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
2 Ghosh TS, Rampelli S, Jeffery IB, Santoro A, Neto M, Capri M, Giampieri E, Jennings A, Candela M, Turroni S, Zoetendal EG, Hermes GDA, Elodie C, Meunier N, Brugere CM, Pujos-Guillot E, Berendsen AM, De Groot LCPGM, Feskins EJM, Kaluza J, Pietruszka B, Bielak MJ, Comte B, Maijo-Ferre M, Nicoletti C, De Vos WM, Fairweather-Tait S, Cassidy A, Brigidi P, Franceschi C, O'Toole PW. Mediterranean diet intervention alters the gut microbiome in older people reducing frailty and improving health status: the NU-AGE 1-year dietary intervention across five European countries. Gut 2020;69:1218-28. [PMID: 32066625 DOI: 10.1136/gutjnl-2019-319654] [Cited by in Crossref: 135] [Cited by in F6Publishing: 129] [Article Influence: 67.5] [Reference Citation Analysis]
3 Hu Y, French SW, Chau T, Liu HX, Sheng L, Wei F, Stondell J, Garcia JC, Du Y, Bowlus CL, Wan YY. RARβ acts as both an upstream regulator and downstream effector of miR-22, which epigenetically regulates NUR77 to induce apoptosis of colon cancer cells. FASEB J 2019;33:2314-26. [PMID: 30252536 DOI: 10.1096/fj.201801390R] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
4 Sagar NM, Cree IA, Covington JA, Arasaradnam RP. The interplay of the gut microbiome, bile acids, and volatile organic compounds. Gastroenterol Res Pract. 2015;2015:398585. [PMID: 25821460 DOI: 10.1155/2015/398585] [Cited by in Crossref: 47] [Cited by in F6Publishing: 31] [Article Influence: 6.7] [Reference Citation Analysis]
5 Liu HX, Rocha CS, Dandekar S, Wan YJ. Functional analysis of the relationship between intestinal microbiota and the expression of hepatic genes and pathways during the course of liver regeneration. J Hepatol 2016;64:641-50. [PMID: 26453969 DOI: 10.1016/j.jhep.2015.09.022] [Cited by in Crossref: 49] [Cited by in F6Publishing: 49] [Article Influence: 8.2] [Reference Citation Analysis]
6 Augustus GJ, Ellis NA. Colorectal Cancer Disparity in African Americans: Risk Factors and Carcinogenic Mechanisms. Am J Pathol. 2018;188:291-303. [PMID: 29128568 DOI: 10.1016/j.ajpath.2017.07.023] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 6.4] [Reference Citation Analysis]
7 Zhang J, Xiong F, Wang G, Li W, Li M, Zou H, Wu S. The influence of diet on the grass carp intestinal microbiota and bile acids. Aquac Res 2017;48:4934-44. [DOI: 10.1111/are.13312] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 2.8] [Reference Citation Analysis]
8 Leoncini E, Carioli G, La Vecchia C, Boccia S, Rindi G. Risk factors for neuroendocrine neoplasms: a systematic review and meta-analysis. Ann Oncol 2016;27:68-81. [PMID: 26487581 DOI: 10.1093/annonc/mdv505] [Cited by in Crossref: 54] [Cited by in F6Publishing: 47] [Article Influence: 7.7] [Reference Citation Analysis]
9 Wu L, Feng J, Li J, Yu Q, Ji J, Wu J, Dai W, Guo C. The gut microbiome-bile acid axis in hepatocarcinogenesis. Biomed Pharmacother 2021;133:111036. [PMID: 33378947 DOI: 10.1016/j.biopha.2020.111036] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
10 Zhu Y, Shui X, Liang Z, Huang Z, Qi Y, He Y, Chen C, Luo H, Lei W. Gut microbiota metabolites as integral mediators in cardiovascular diseases (Review). Int J Mol Med 2020;46:936-48. [PMID: 32705240 DOI: 10.3892/ijmm.2020.4674] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
11 Sheng L, Jena PK, Hu Y, Liu HX, Nagar N, Kalanetra KM, French SW, Mills DA, Wan YY. Hepatic inflammation caused by dysregulated bile acid synthesis is reversible by butyrate supplementation.J Pathol. 2017;243:431-441. [PMID: 28892150 DOI: 10.1002/path.4983] [Cited by in Crossref: 56] [Cited by in F6Publishing: 56] [Article Influence: 11.2] [Reference Citation Analysis]
12 Ge Y, Wang X, Guo Y, Yan J, Abuduwaili A, Aximujiang K, Yan J, Wu M. Gut microbiota influence tumor development and Alter interactions with the human immune system. J Exp Clin Cancer Res 2021;40:42. [PMID: 33494784 DOI: 10.1186/s13046-021-01845-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
13 Shafiee S, Cegolon L, Khafaei M, Gholami N, Zhao S, Khalesi N, Moosavian H, Fathi S, Izadi M, Ghadian A, Javanbakht M, Javanbakht A, Akhavan-Sigari R. Gastrointestinal cancers, ACE-2/TMPRSS2 expression and susceptibility to COVID-19. Cancer Cell Int 2021;21:431. [PMID: 34399734 DOI: 10.1186/s12935-021-02129-x] [Reference Citation Analysis]
14 Sepe V, Distrutti E, Fiorucci S, Zampella A. Farnesoid X receptor modulators (2011 – 2014): a patent review. Expert Opinion on Therapeutic Patents 2015;25:885-96. [DOI: 10.1517/13543776.2015.1045413] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
15 Manzat-Saplacan RM, Mircea PA, Balacescu L, Chira RI, Berindan-Neagoe I, Balacescu O. Can we change our microbiome to prevent colorectal cancer development? Acta Oncol 2015;54:1085-95. [PMID: 26073561 DOI: 10.3109/0284186X.2015.1054949] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
16 Ghosh TS, Das M, Jeffery IB, O'Toole PW. Adjusting for age improves identification of gut microbiome alterations in multiple diseases. Elife 2020;9:e50240. [PMID: 32159510 DOI: 10.7554/eLife.50240] [Cited by in Crossref: 30] [Cited by in F6Publishing: 13] [Article Influence: 15.0] [Reference Citation Analysis]
17 McCombe PA, Henderson RD, Lee A, Lee JD, Woodruff TM, Restuadi R, McRae A, Wray NR, Ngo S, Steyn FJ. Gut microbiota in ALS: possible role in pathogenesis? Expert Rev Neurother 2019;19:785-805. [PMID: 31122082 DOI: 10.1080/14737175.2019.1623026] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
18 Saber A, Alipour B, Faghfoori Z, Yari Khosroushahi A. Cellular and molecular effects of yeast probiotics on cancer. Crit Rev Microbiol 2017;43:96-115. [PMID: 27561003 DOI: 10.1080/1040841X.2016.1179622] [Cited by in Crossref: 20] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
19 Jena PK, Sheng L, Di Lucente J, Jin LW, Maezawa I, Wan YY. Dysregulated bile acid synthesis and dysbiosis are implicated in Western diet-induced systemic inflammation, microglial activation, and reduced neuroplasticity. FASEB J. 2018;32:2866-2877. [PMID: 29401580 DOI: 10.1096/fj.201700984rr] [Cited by in Crossref: 38] [Cited by in F6Publishing: 25] [Article Influence: 9.5] [Reference Citation Analysis]
20 Jena PK, Sheng L, Li Y, Wan YY. Probiotics VSL#3 are effective in reversing non-alcoholic steatohepatitis in a mouse model. Hepatobiliary Surg Nutr 2020;9:170-82. [PMID: 32355675 DOI: 10.21037/hbsn.2019.09.07] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
21 Zhang Y, Kang C, Wang X, Zhou M, Chen M, Zhu X, Liu K, Wang B, Zhang Q, Zhu J, Mi M. Dietary Factors Modulate Colonic Tumorigenesis Through the Interaction of Gut Microbiota and Host Chloride Channels. Mol Nutr Food Res 2018;62:1700554. [DOI: 10.1002/mnfr.201700554] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
22 Cao H, Xu M, Dong W, Deng B, Wang S, Zhang Y, Wang S, Luo S, Wang W, Qi Y. Secondary bile acid-induced dysbiosis promotes intestinal carcinogenesis. Int J Cancer. 2017;140:2545-2556. [PMID: 28187526 DOI: 10.1002/ijc.30643] [Cited by in Crossref: 77] [Cited by in F6Publishing: 74] [Article Influence: 15.4] [Reference Citation Analysis]
23 Liu HX, Hu Y, Wan YJ. Microbiota and bile acid profiles in retinoic acid-primed mice that exhibit accelerated liver regeneration. Oncotarget 2016;7:1096-106. [PMID: 26701854 DOI: 10.18632/oncotarget.6665] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 4.3] [Reference Citation Analysis]
24 Gray MA, James Squires E. Investigation of the dominant positive effect of porcine farnesoid X receptor (FXR) splice variant 1. Gene. 2015;560:71-76. [PMID: 25623328 DOI: 10.1016/j.gene.2015.01.046] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
25 Chen ML, Takeda K, Sundrud MS. Emerging roles of bile acids in mucosal immunity and inflammation. Mucosal Immunol. 2019;12:851-861. [PMID: 30952999 DOI: 10.1038/s41385-019-0162-4] [Cited by in Crossref: 54] [Cited by in F6Publishing: 56] [Article Influence: 18.0] [Reference Citation Analysis]
26 Khalyfa A, Qiao Z, Raju M, Shyu CR, Coghill L, Ericsson A, Gozal D. Monocarboxylate Transporter-2 Expression Restricts Tumor Growth in a Murine Model of Lung Cancer: A Multi-Omic Analysis. Int J Mol Sci 2021;22:10616. [PMID: 34638954 DOI: 10.3390/ijms221910616] [Reference Citation Analysis]
27 Jena PK, Sheng L, Liu HX, Kalanetra KM, Mirsoian A, Murphy WJ, French SW, Krishnan VV, Mills DA, Wan YY. Western Diet-Induced Dysbiosis in Farnesoid X Receptor Knockout Mice Causes Persistent Hepatic Inflammation after Antibiotic Treatment. Am J Pathol 2017;187:1800-13. [PMID: 28711154 DOI: 10.1016/j.ajpath.2017.04.019] [Cited by in Crossref: 55] [Cited by in F6Publishing: 51] [Article Influence: 11.0] [Reference Citation Analysis]
28 Chen R, Liao C, Guo Q, Wu L, Zhang L, Wang X. Combined systems pharmacology and fecal metabonomics to study the biomarkers and therapeutic mechanism of type 2 diabetic nephropathy treated with Astragalus and Leech. RSC Adv 2018;8:27448-63. [DOI: 10.1039/c8ra04358b] [Cited by in Crossref: 8] [Article Influence: 2.0] [Reference Citation Analysis]
29 Sipos A, Ujlaki G, Mikó E, Maka E, Szabó J, Uray K, Krasznai Z, Bai P. The role of the microbiome in ovarian cancer: mechanistic insights into oncobiosis and to bacterial metabolite signaling. Mol Med 2021;27:33. [PMID: 33794773 DOI: 10.1186/s10020-021-00295-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
30 Shavandi A, Saeedi P, Gérard P, Jalalvandi E, Cannella D, Bekhit AE. The role of microbiota in tissue repair and regeneration. J Tissue Eng Regen Med 2020;14:539-55. [PMID: 31845514 DOI: 10.1002/term.3009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
31 Liu T, Yang Z, Zhang X, Han N, Yuan J, Cheng Y. 16S rDNA analysis of the effect of fecal microbiota transplantation on pulmonary and intestinal flora. 3 Biotech 2017;7:370. [PMID: 29071167 DOI: 10.1007/s13205-017-0997-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
32 Nigam SK, Bush KT, Bhatnagar V, Poloyac SM, Momper JD. The Systems Biology of Drug Metabolizing Enzymes and Transporters: Relevance to Quantitative Systems Pharmacology. Clin Pharmacol Ther 2020;108:40-53. [PMID: 32119114 DOI: 10.1002/cpt.1818] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
33 Davoren MJ, Schiestl RH. Glyphosate-based herbicides and cancer risk: a post-IARC decision review of potential mechanisms, policy and avenues of research. Carcinogenesis 2018;39:1207-15. [PMID: 30060078 DOI: 10.1093/carcin/bgy105] [Cited by in Crossref: 37] [Cited by in F6Publishing: 22] [Article Influence: 12.3] [Reference Citation Analysis]
34 Xie G, Wang X, Zhao A, Yan J, Chen W, Jiang R, Ji J, Huang F, Zhang Y, Lei S, Ge K, Zheng X, Rajani C, Alegado RA, Liu J, Liu P, Nicholson J, Jia W. Sex-dependent effects on gut microbiota regulate hepatic carcinogenic outcomes. Sci Rep 2017;7:45232. [PMID: 28345673 DOI: 10.1038/srep45232] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 7.6] [Reference Citation Analysis]
35 Jena PK, Sheng L, Nagar N, Wu C, Barile D, Mills DA, Wan YY. Synbiotics Bifidobacterium infantis and milk oligosaccharides are effective in reversing cancer-prone nonalcoholic steatohepatitis using western diet-fed FXR knockout mouse models. J Nutr Biochem 2018;57:246-54. [PMID: 29800811 DOI: 10.1016/j.jnutbio.2018.04.007] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 6.0] [Reference Citation Analysis]
36 Huang YW, Lin CW, Pan P, Echeveste CE, Dong A, Oshima K, Yearsley M, Yu J, Wang LS. Dysregulated Free Fatty Acid Receptor 2 Exacerbates Colonic Adenoma Formation in Apc Min/+ Mice: Relation to Metabolism and Gut Microbiota Composition. J Cancer Prev 2021;26:32-40. [PMID: 33842404 DOI: 10.15430/JCP.2021.26.1.32] [Reference Citation Analysis]
37 Hu Y, Liu HX, Jena PK, Sheng L, Ali MR, Wan YY. miR-22 inhibition reduces hepatic steatosis via FGF21 and FGFR1 induction. JHEP Rep 2020;2:100093. [PMID: 32195457 DOI: 10.1016/j.jhepr.2020.100093] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
38 Liu HX, Keane R, Sheng L, Wan YJ. Implications of microbiota and bile acid in liver injury and regeneration. J Hepatol. 2015;63:1502-1510. [PMID: 26256437 DOI: 10.1016/j.jhep.2015.08.001] [Cited by in Crossref: 63] [Cited by in F6Publishing: 65] [Article Influence: 9.0] [Reference Citation Analysis]
39 Erice O, Labiano I, Arbelaiz A, Santos-laso A, Munoz-garrido P, Jimenez-agüero R, Olaizola P, Caro-maldonado A, Martín-martín N, Carracedo A, Lozano E, Marin J, O'rourke C, Andersen J, Llop J, Gómez-vallejo V, Padro D, Martin A, Marzioni M, Adorini L, Trauner M, Bujanda L, Perugorria M, Banales J. Differential effects of FXR or TGR5 activation in cholangiocarcinoma progression. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018;1864:1335-44. [DOI: 10.1016/j.bbadis.2017.08.016] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 7.5] [Reference Citation Analysis]
40 Hirsch N, Konstantinov A, Anavi S, Aronis A, Hagay Z, Madar Z, Tirosh O. Prolonged feeding with green tea polyphenols exacerbates cholesterol-induced fatty liver disease in mice. Mol Nutr Food Res 2016;60:2542-53. [PMID: 27432221 DOI: 10.1002/mnfr.201600221] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 4.7] [Reference Citation Analysis]
41 Hegyi P, Maléth J, Walters JR, Hofmann AF, Keely SJ. Guts and Gall: Bile Acids in Regulation of Intestinal Epithelial Function in Health and Disease. Physiol Rev 2018;98:1983-2023. [PMID: 30067158 DOI: 10.1152/physrev.00054.2017] [Cited by in Crossref: 81] [Cited by in F6Publishing: 76] [Article Influence: 27.0] [Reference Citation Analysis]
42 Hu H, Wu LL, Han T, Zhuo M, Lei W, Cui JJ, Jiao F, Wang LW. Correlated high expression of FXR and Sp1 in cancer cells confers a poor prognosis for pancreatic cancer: A study based on TCGA and tissue microarray. Oncotarget 2017;8:33265-75. [PMID: 28402278 DOI: 10.18632/oncotarget.16633] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
43 Feng ZM, Li TJ, Wu L, Xiao DF, Blachier F, Yin YL. Monosodium L-Glutamate and Dietary Fat Differently Modify the Composition of the Intestinal Microbiota in Growing Pigs. Obes Facts 2015;8:87-100. [PMID: 25791341 DOI: 10.1159/000380889] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
44 Chang HJ, Zúñiga A, Conejero I, Voyvodic PL, Gracy J, Fajardo-Ruiz E, Cohen-Gonsaud M, Cambray G, Pageaux GP, Meszaros M, Meunier L, Bonnet J. Programmable receptors enable bacterial biosensors to detect pathological biomarkers in clinical samples. Nat Commun 2021;12:5216. [PMID: 34471137 DOI: 10.1038/s41467-021-25538-y] [Reference Citation Analysis]
45 Wang CS, Liu SH, Peng J, Tang C, Zhu WG. Bile acids cycle disruption in patients with nasopharyngeal carcinoma promotes the elevation of interleukin-10 secretion. Afr Health Sci 2015;15:1200-3. [PMID: 26958021 DOI: 10.4314/ahs.v15i4.19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
46 Chen MC, Chen YL, Wang TW, Hsu HP, Lai MD. Membrane bile acid receptor TGR5 predicts good prognosis in ampullary adenocarcinoma patients with hyperbilirubinemia. Oncol Rep 2016;36:1997-2008. [PMID: 27510297 DOI: 10.3892/or.2016.5011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
47 Kiss B, Mikó E, Sebő É, Toth J, Ujlaki G, Szabó J, Uray K, Bai P, Árkosy P. Oncobiosis and Microbial Metabolite Signaling in Pancreatic Adenocarcinoma. Cancers (Basel) 2020;12:E1068. [PMID: 32344895 DOI: 10.3390/cancers12051068] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
48 Zhou H, Zhou SY, Gillilland M 3rd, Li JY, Lee A, Gao J, Zhang G, Xu X, Owyang C. Bile acid toxicity in Paneth cells contributes to gut dysbiosis induced by high-fat feeding. JCI Insight 2020;5:138881. [PMID: 33055426 DOI: 10.1172/jci.insight.138881] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]